glp 1 low dose therapy GLP-1 drugs: Lower or oral pill may help sustain weight loss Starting GLP-1 medications at lower

The relatively low incidence of serious safety concerns supports the continued development and use of peptide therapeutics, although ongoing monitoring and research remain important for optimizing their clinical application

The GLP-1 class of drugs has revolutionized the treatment of diabetes and obesity while also reducing cardiovascular adverse events

Several states are dropping weight loss coverage of GLP-1s from their version of Medicaid, including California's Medi-cal program

There was an inverse correlation observed between CCL11 mRNA levels and methylation levels of specific cytosines in its promoter region